Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Apr 26:9:904738.
doi: 10.3389/fcvm.2022.904738. eCollection 2022.

Editorial: The Analysis of Nanovesicles, Biomaterials and Chemical Compounds: Assisting the Promotion of Angiogenesis and Enhancing Tissue Engineering Strategies

Affiliations
Editorial

Editorial: The Analysis of Nanovesicles, Biomaterials and Chemical Compounds: Assisting the Promotion of Angiogenesis and Enhancing Tissue Engineering Strategies

Vincenzo Lionetti et al. Front Cardiovasc Med. .
No abstract available

Keywords: cardiac repair; cardiovascular disease; extracellular veiscles; nanomaterials; nanovesicles; stem cells; tissue engineering.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Different approaches for cardiac regeneration. Cell therapy using stem cells can help treat the damaged myocardium. These stem cells enriched with different biomolecules can exhibit positive effects on the heart muscle. The extracellular vesicles released from stem cells have also emerged as excellent source of therapeutic agents. Using specially engineered biomaterials aids in creating a 3D microenvironment which can be injected alone or in combination with stem cells.

Comment on

  • Editorial on the Research Topic The Analysis of Nanovesicles, Biomaterials and Chemical Compounds: Assisting the Promotion of Angiogenesis and Enhancing Tissue Engineering Strategies

Similar articles

Cited by

References

    1. Dhingra S, Li P, Huang X-P, Guo J, Wu J, Mihic A, et al. . Preserving prostaglandin E2 level prevents rejection of implanted allogeneic mesenchymal stem cells and restores postinfarction ventricular function. Circulation. (2013) 128:S69–78. 10.1161/CIRCULATIONAHA.112.000324 - DOI - PubMed
    1. Abu-El-Rub E, Sequiera GL, Sareen N, Yan W, Moudgil M, Sabbir MG, et al. . Hypoxia-induced 26S proteasome dysfunction increases immunogenicity of mesenchymal stem cells. Cell Death Dis. (2019) 10:1–17. 10.1038/s41419-019-1359-x - DOI - PMC - PubMed
    1. Yan W, Abu-El-Rub E, Saravanan S, Kirshenbaum LA, Arora RC, Dhingra S. Inflammation in myocardial injury: mesenchymal stem cells as potential immunomodulators. Am J Physiol-Heart Circ Physiol. (2019) 317:H213–25. 10.1152/ajpheart.00065.2019 - DOI - PMC - PubMed
    1. Oikonomopoulos A, Kitani T, Wu JC. Pluripotent stem cell-derived cardiomyocytes as a platform for cell therapy applications: progress and hurdles for clinical translation. Mol Ther. (2018) 26:1624–34. 10.1016/j.ymthe.2018.02.026 - DOI - PMC - PubMed
    1. Batalov I, Feinberg AW. Differentiation of cardiomyocytes from human pluripotent stem cells using monolayer culture. Biomark Insights. (2015) 10:71–6. 10.4137/BMI.S20050 - DOI - PMC - PubMed

Publication types

LinkOut - more resources